Edward Gordon-Smith, MD

Most recent by Edward Gordon-Smith, MD

SPONSORED CONTENT
November 25, 2011
8 min read
Save

Annual congress highlights benefits of tailoring treatment to disease risk factors, patients’ status

Annual congress highlights benefits of tailoring treatment to disease
		risk factors, patients’ status

The European Haematology Association’s annual congress took place in June in London. A number of themes emerged from this large and interesting meeting, which spotlighted several exciting and meaningful therapeutic advances.

SPONSORED CONTENT
July 01, 2007
5 min read
Save

Paroxysmal nocturnal hemoglobinuria, eculizumab and hemolysis: the SHEPHERD trial

Paroxysmal nocturnal hemoglobinuria, eculizumab and hemolysis: the SHEPHERD trial

Paroxysmal nocturnal hemoglobinuria is a rare disorder that has fascinated clinicians and scientists for more than a hundred years.